NVOX Stock Summary and Trading Ideas (Tidal Trust II Defiance Daily Target 2X Long Nvo ETF | ARCA:NVOX)

The Defiance Daily Target 2X Long NVO ETF (the "Fund") seeks daily leveraged investment results of two times (200%) the daily percentage change in the share price of NOVO Nordisk A/S - ADR (NYSE: NVO) (the "Underlying Security" or "NVO"). NVOX does not invest directly in NOVO. NOVO Nordisk A/S ("Novo Nordisk") is a Danish global pharmaceutical company. Novo Nordisk manufactures and markets pharmaceutical products and services, specifically to provide diabetes care and other chronic conditions like obesity, hemophilia, and growth disorders. It is also involved with hemostasis management, growth hormone therapy, and hormone replacement therapy. The Fund will seek to achieve its objective with respect to Novo Nordisk's American Depositary Receipt (NYSE: NVO).

Tidal Trust II Defiance Daily Target 2X Long Nvo ETF trades on the ARCA stock market under the symbol NVOX.

As of January 3, 2025, NVOX stock price climbed to $12.14 with 37,565 million shares trading.

NVOX has a market cap of $2.43 million. This is considered a Sub-Micro Cap stock.

NVOX support price is $11.09 and resistance is $13.15 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NVOX shares will trade within this expected range on the day.